ANIP EPS Estimates
ANI Pharmaceuticals, Inc.
$70.16
-$0.68(-0.96%)
52
Overall
75
Value
30
Tech
52
Quality
Market Cap
$1.61B
Volume
269.20K
52W Range
$69.58 - $97.00
Target Price
$102.80
ANIP EPS estimates: the consensus estimate for ANI Pharmaceuticals, Inc.'s current fiscal year is $7.76 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ANIP EPS Estimates
- EPS estimate, current quarter
- $1.80
- EPS estimate, next quarter
- $2.43
- EPS estimate, current year
- $7.76
- EPS estimate, next year
- $8.41
- EPS growth, 3-year
- +46.55%
| Fiscal year | EPS |
|---|---|
| 2025 | $3.50 |
| 2024 | $-1.04 |
| 2023 | $0.86 |
| 2022 | $-3.05 |
| 2021 | $-3.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANIP | $70.16 | -1.0% | 269.20K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ANI Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW